On September 23, 2026 (the "EffectiveDate"), Sarepta Therapeutics, Inc. (the "Company"), Sarepta Therapeutics Three, LLC ("Sarepta Three" and, together with the Company, "Sarepta"), REGENXBIO Inc.
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... 0.5 ... 2 ... Sarepta Therapeutics, Inc ... 6 ... Sarepta Therapeutics Inc.